What Researchers Did
Researchers retrospectively studied ten patients with invasive aspergillosis who received adjunctive hyperbaric oxygenation (HBO) along with standard care, assessing survival at 3 months.
What They Found
Out of ten patients with invasive aspergillosis, primarily presenting with rhinosinusinal infection and underlying hematologic malignancies, all received adjunctive hyperbaric oxygenation. Six of these ten patients (60%) were free of signs of infection three months after their initial hyperbaric oxygen treatment.
Canadian Relevance
This study has no direct Canadian connection as it was conducted at a single institution outside of Canada.
Study Limitations
Key limitations include the retrospective design, the very small sample size of ten patients, and its conduct at a single institution.